Search results
15 wrz 2020 · Survival has improved, but varies widely by GPA for patients with non–small-cell lung, breast, melanoma, GI, and renal cancer with brain metastases from 7-47 months, 3-36 months, 5-34 months, 3-17 months, and 4-35 months, respectively. Conclusion.
- PDF
PURPOSEConventional wisdom has rendered patients with brain...
- Journal of Clinical Oncology
Founded in 1964, the American Society of Clinical Oncology,...
- PDF
Survival has improved, but varies widely by GPA for patients with non–small-cell lung, breast, melanoma, GI, and renal cancer with brain metastases from 7-47 months, 3-36 months, 5-34 months, 3-17 months, and 4-35 months, respectively. CONCLUSION.
These persons also have a longer life expectancy compared to patients with AD. For these reasons, the relation between cancer and AD could be explored with less influence of biases using MCI as a proxy for dementia.
24 sie 2005 · In this case study, we describe a patient with a dementia due to a brain tumor. This unusual cause of dementia illustrates the importance of a thorough evaluation of anyone who experiences relatively sudden changes in cognitive functions.
30 sie 2023 · Abstract. Purpose. This study aimed to assess clinical, treatment, and prognostic features in patients with brain metastases (BM) from solid tumors achieving long-term survival (LTS). Further, the accuracy of diagnosis-specific Graded Prognostic Assessment scores (ds-GPA) to predict LTS was evaluated. Methods.
12 maj 2022 · Median survival was 0.7 months in the worst prognostic group of the latter score, with a hazard ratio for death of 44 (95% confidence interval (CI), 6–340) compared to the best group. However, many patients with short survival were not assigned to the worst group.
The life expectancy associated with brain metastases was once less than six months. But new treatments have extended the timeline so that most people with this diagnosis are living longer and with much better symptom management.
